Sandy Spring Bank Fulgent Genetics, Inc. Transaction History

Sandy Spring Bank

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 05, 2023	SELL	$29.39 - $36.27 $5,878 - $7,254	-200 Reduced 54.35%	168 $5,000
Q4 2022 Feb 10, 2023	SELL	$29.23 - $40.28 $4,910 - $6,767	-168 Reduced 31.34%	368 $10,000
Q3 2022 Nov 02, 2022	BUY	$37.92 - $63.74 $7,584 - $12,748	200 Added 59.52%	536 $21,000
Q1 2021 May 03, 2021	BUY	$59.3 - $183.85 $8,302 - $25,739	140 Added 71.43%	336 $32,000
Q4 2020 Feb 03, 2021	BUY	$31.01 - $52.1 $6,077 - $10,211	196 New	196 $10,000

198

16.1M

2.04M

14K

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $504M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

Get notified when there are updates to the investment portfolio of Sandy Spring Bank, based on Form 13F filings with the SEC.

Stay updated on Sandy Spring Bank with notifications on news.